AIM
NBSE

Acrospire Investment Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Acrospire Investment Management’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1
Closed – – 2610
2017
Q1 		$0 Sell
1
-27
-96% – ﹤0.01% 2566
2016
Q4 		$17K Buy
28
+12
+75% +$7.29K 0.01% 1825
2016
Q3 		$18K Sell
16
-20
-56% -$22.5K 0.01% 1540
2016
Q2 		$39K Buy
+36
New +$39K 0.03% 1242